New York Pharmacy Lien Laws for Personal Injury Attorneys

James Wong — Founder & Pharmacist, LienScripts | February 13, 2026 | 8 min read

New York's no-fault auto insurance system, serious injury threshold, and No-Fault Law create a complex PI environment. Understanding how pharmacy liens interact with NY No-Fault Basic Economic Loss and the serious injury threshold is essential for New York PI attorneys.

New York's No-Fault System: The Foundation

New York is a mandatory no-fault state under the Comprehensive Motor Vehicle Insurance Reparations Act, codified at NY Insurance Law § 5101 et seq.. Every registered motor vehicle in New York must carry Personal Injury Protection (PIP) providing at least $50,000 in Basic Economic Loss (BEL) coverage.

New York's PIP is among the most generous in the country — $50,000 covers:

• Medical expenses (including physician visits, hospitalizations, and prescriptions)
• Lost wages (80% of actual wages, up to $2,000/month for 3 years)
• Other reasonable and necessary expenses

The 30-day rule: Under 11 NYCRR § 65-3.5, no-fault insurers must pay or deny claims within 30 days of receiving written proof of claim. This creates a specific procedural pressure on NY PIP claims — insurers that miss the 30-day deadline may forfeit their denial rights.

The Serious Injury Threshold

New York's no-fault system is a threshold system: injured parties can sue in tort for pain and suffering only if their injury qualifies as a "serious injury" under NY Insurance Law § 5102(d).

The serious injury categories:

• Death
• Dismemberment
• Significant disfigurement
• Fracture
• Loss of a fetus
• Permanent loss of use of a body organ, member, function, or system
• Permanent consequential limitation of use of a body organ or member
• Significant limitation of use of a body function or system
• A medically determined injury or impairment of a non-permanent nature which prevents the plaintiff from performing substantially all of the material acts which constitute such person's usual and customary daily activities for not less than 90 out of the first 180 days following the occurrence of the injury

The pharmacy record's role in the serious injury analysis:

The threshold categories of "significant limitation," "permanent consequential limitation," and "90/180 days" disability are all supported by the completeness and continuity of the pharmacy record. A client who has been filling pain management, muscle relaxant, nerve pain, and sleep medications continuously for 90+ days has a medication record that corroborates the 90/180-day disability category. The MERIT provides a date-stamped pharmaceutical record that tracks the treatment timeline.

[!KEY] The 90/180-day serious injury threshold is a paperwork battle — and the pharmacy record is some of the best paper in the file. A complete MERIT showing 90+ consecutive days of injury-related prescription filling corroborates the plaintiff's disability claim in a way that self-reported symptoms cannot.

[!KEY] New York no-fault IME denials are one of the most common reasons PI clients lose prescription coverage mid-treatment. A pharmacy lien enrolled at intake creates a backup coverage mechanism that activates the moment no-fault benefits are cut — ensuring the client's treatment record has no gap that defense can exploit.

NY No-Fault and Pharmacy Lien Interaction

When does a pharmacy lien apply in New York?

New York's $50,000 BEL is substantial, but it can be exhausted in serious injury cases:

• A single hospitalization with surgery can consume most of the BEL
• Ongoing physical therapy, specialist visits, and medications together can exhaust $50,000 within 6–12 months in a catastrophic injury case

When BEL exhausts, the client faces out-of-pocket costs for ongoing medications. A pharmacy lien covers this gap at $0 upfront.

IME denials:

New York no-fault insurers routinely use Independent Medical Examinations (IMEs) to deny continued no-fault benefits. When a no-fault IME physician concludes that the client has reached maximum medical benefit, the insurer may cut off no-fault pharmacy benefits even while the client is still actively treating.

A pharmacy lien is the access mechanism when no-fault IME denial cuts off prescription benefits mid-treatment. The client continues to fill medications through the lien program; the lien resolves from the tort settlement if the serious injury threshold is met.

No-fault does not preclude pharmacy lien enrollment:

Some NY attorneys assume that active no-fault coverage means a pharmacy lien is unnecessary. This is incorrect for several reasons:

1. No-fault may be cut by IME denial before the client reaches MMI
2. Certain medications may be excluded from no-fault coverage (experimental, off-label, non-preferred)
3. The client may have a no-fault dispute pending while simultaneously needing medications
4. The pharmacy lien creates a MERIT record even when no-fault is paying — establishing a complete pharmaceutical record for the tort case

New York's Lien Framework for Healthcare Providers

New York does not have a single comprehensive healthcare lien statute. Provider lien rights arise from:

Contractual assignment: The most common mechanism for pharmacy lien programs — the patient assigns a portion of PI recovery to the pharmacy provider. New York courts respect contractual assignments of tort proceeds.

NY General Obligations Law § 5-335: This statute limits the enforceability of certain assignment agreements against no-fault benefits — but does not prohibit contractual assignment of liability/tort settlement proceeds. Pharmacy lien programs operating on contractual assignment of PI recovery (not no-fault benefits) are fully operative in New York.

Hospital lien rights: Under NY Lien Law § 189, hospitals have lien rights on PI settlements for services rendered. The hospital lien is separate from and does not preempt pharmacy lien programs.

[!KEY] New York's contractual assignment mechanism for pharmacy lien programs is well-established — the patient assigns a portion of tort recovery to the lien program in exchange for zero-upfront prescriptions. New York's General Obligations Law does not prohibit this assignment of liability settlement proceeds, making pharmacy liens fully operative statewide.

New York City vs. Upstate NY

New York City: The five boroughs represent one of the country's most active PI markets. The Civil Court of the City of New York and the Supreme Court (First and Second Departments) handle enormous PI caseloads. The NYC market features:

• Significant subway, bus, and taxi/rideshare accident litigation
• Pedestrian knockdown cases on high-traffic corridors
• Construction accident cases under Labor Law § 240(1) (the "scaffold law") — one of the most plaintiff-favorable construction liability statutes in the country
• High-value cases due to NYC wage levels and medical cost benchmarks

Upstate NY: Buffalo, Rochester, Syracuse, and Albany have active PI markets with different demographics and jury expectations. Upstate cases are often highway accident cases on I-90, I-87, and I-81.

[!NOTE] New York's scaffold law (Labor Law § 240(1)) imposes absolute liability on owners and general contractors for gravity-related construction accidents. Construction workers injured in scaffold falls, unsecured equipment falls, or similar gravity incidents in NYC pursue scaffold law claims alongside workers' comp — and their medication needs from orthopedic and neurological injuries benefit from pharmacy lien programs in the same way as any PI case.

Related Resources

• Pharmacy Lien Services in New York City
• What Is a No-Fault State? PI Pharmacy Access Explained
• Pharmacy Lien Laws by State
• What Is an Independent Medical Examination?
• Pharmacy Services for Personal Injury Clients

[!SOURCE] NY Insurance Law § 5102 — Definitions of Basic Economic Loss and Serious Injury — New York's statutory definition of "serious injury" threshold categories and "basic economic loss" for no-fault coverage purposes.

[!SOURCE] 11 NYCRR § 65-3.5 — No-Fault Claims Processing Regulations — New York's no-fault insurance regulations governing claim processing timelines, including the 30-day pay-or-deny requirement.